The Relationship Between Body Mass Index and Patient Outcomes in Low Flow Anaesthesia

August 12, 2025 updated by: Duygu Akyol, Bakirkoy Dr. Sadi Konuk Research and Training Hospital

The Effect of Body Mass Index on Patient Outcomes During Low-flow Anaesthesia for Major Gynaecological Cancer Surgery: a Prospective Observational Study

This study was designed as a prospective observational study.

Study Overview

Detailed Description

In this study, it was planned to evaluate the effect of body mass index on patient outcomes during low flow anaesthesia in patients undergoing gynaecological cancer surgery on the specified dates. ASA II and III patients over 18 years of age were included in the study. Low flow anaesthesia is routinely applied in open gynaecological cancer surgeries in our clinic. The relationship between body mass index and intraoperative haemodynamic and mechanical ventilator values and postoperative patient outcomes will be evaluated.

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • Duygu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

A total of 40 patients were planned for this study

Description

Inclusion Criteria:

  • Patients with ASA II-III
  • >18 years
  • Patients undergoing major open surgery for endometrium, cervix or ovarian ca in gynaecological oncology clinic

Exclusion Criteria:

  • Patients who refused to participate in the study
  • Cerebrovascular disease
  • Those with severe pulmonary disease
  • Those with serious cardiovascular disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
obese patients undergoing low-flow anaesthesia
Low-flow anaesthesia was performed in patients with a body mass index between 30-40
The investigator planned to evaluate the effect of body mass index on patient outcomes during low-flow anesthesia in patients undergoing gynecologic cancer surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postoperative hospital stay
Time Frame: up to 10 days postoperative
The primary aim of this study was to evaluate the duration of postoperative hospital stay
up to 10 days postoperative

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative cerebral oxygenation
Time Frame: intraoperative process
Our other aim was to evaluate right and left hemisphere cerebral oxygenation at certain time periods.
intraoperative process

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2024

Primary Completion (Actual)

February 1, 2025

Study Completion (Actual)

March 1, 2025

Study Registration Dates

First Submitted

September 27, 2024

First Submitted That Met QC Criteria

October 9, 2024

First Posted (Actual)

October 10, 2024

Study Record Updates

Last Update Posted (Actual)

August 13, 2025

Last Update Submitted That Met QC Criteria

August 12, 2025

Last Verified

September 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe